Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Express Scripts
Harvard Business School
AstraZeneca
Merck

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Dapivirine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Dapivirine: Sponsors, patents, clinical trial progress

Dapivirine is an investigational drug.

There have been 39 clinical trials for Dapivirine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Immunologic Deficiency Syndromes. The leading clinical trial sponsors are International Partnership for Microbicides, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and National Institutes of Health (NIH).

There are twenty-nine US patents protecting this investigational drug and six hundred and ninety-nine international patents.

Recent Clinical Trials for Dapivirine
TitleSponsorPhase
Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyNational Institute of Allergy and Infectious Diseases (NIAID)Phase 3
Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female PopulationNational Institute of Allergy and Infectious Diseases (NIAID)Phase 2
PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and LevonorgestrelDivision of AIDS, US National Institute of Allergy and Infectious DiseasesPhase 1

See all Dapivirine clinical trials

Clinical Trial Summary for Dapivirine

Top disease conditions for Dapivirine
Top clinical trial sponsors for Dapivirine

See all Dapivirine clinical trials

US Patents for Dapivirine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dapivirine   See Pricing Combination therapy intravaginal rings International Partnership for Microbicides, Inc. (Silver Spring, MD)   See Pricing
Dapivirine   See Pricing HIV inhibiting pyrimidine derivative Janssen Pharmaceutica, Inc. (New Brunswick, NJ)   See Pricing
Dapivirine   See Pricing HIV Inhibiting pyrimidine derivatives Janssen Pharmaceutica, N.V. (Beerse, BE)   See Pricing
Dapivirine   See Pricing HIV inhibiting pyrimidine derivatives   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dapivirine

Drugname Country Document Number Estimated Expiration Related US Patent
Dapivirine African Regional IP Organization (ARIPO) 1468 2018-03-27   See Pricing
Dapivirine Argentina 014785 2018-03-27   See Pricing
Dapivirine Austria 232521 2018-03-27   See Pricing
Dapivirine Austria 500231 2018-03-27   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Mallinckrodt
AstraZeneca
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.